Live data from Hacker News

Viewing profile — tclmeelmo

tclmeelmo

HN member
Joined
Fri, Feb 19, 2016, 6:34 PM UTC
HN karma
264
Public activity
100 items

About tclmeelmo

I have donkey brains.

Recent public activity

  1. comment
  2. comment
  3. comment
    Comment #11691020

    Someone on Youtube had what I thought was a clever solution: a piece of trim (looked like shoe molding) to bridge the 1" step. Cheap, and they claimed 100% effective.

  4. comment
  5. comment
    Comment #11686311

    IIRC, the HP-15C used LU decomposition in its matrix math routines.

  6. comment
    Comment #11679666

    > It also is very sensitive to resistance, to the point that I actually had to construct ramps for my car to climb the 1-inch lip at the entrance to my garage, otherwise it would s…

  7. comment
    Comment #11679411

    It would also seem possible for a spouse or other alternate driver of the car to have disabled those safeguards.

  8. comment
    Comment #11679288

    This feature has me wondering what the SAE standards for automatic transmissions have to say on the matter, if anything? I'm not familiar with them, nor do I have access, but I'm h…

  9. story
  10. comment
    Comment #11555810

    I am under the impression that they were experienced in IT but inexperienced in biomedical investments.

  11. comment
    Comment #11555659

    This is really interesting. Do you know of anyone using it in production?

  12. comment
    Comment #11550468

    An interesting question for me is, what will be the effect on wellness startups doing things like Fitbit or Soylent? I have no idea.

  13. comment
  14. comment
    Comment #11550010

    Experienced investors aren't going to invest much if the science isn't on a good foundation. Even if they would, that's a pretty expensive way to fund research: it's cheaper to fun…

  15. comment
    Comment #11549887

    I would predict that it depends on where the money is coming from. For VC firms that are experienced in the biomedical space, Theranos changes nothing because they were already sus…

  16. comment
    Comment #11549716

    This article (by way of the WSJ) claims that Walgreens skipped their standard DD in partnering with Theranos, and that the deal overall was atypically structured.

  17. comment
    Comment #11545661

    I remember playing around with REBOL a long time ago and it seemed useful and practical, but for reasons long forgotten I never used it. Maybe licensing? RED does look cool and I h…

  18. comment
    Comment #11545076

    I only use it like you guessed (and what I think it's best/appropriate for): gluing things together, embedded scripting, and Tk on internal tools/gizmos and early prototypes. I was…

  19. comment
    Comment #11539773

    In terms of acceleration they're certainly impressive, but does any Tesla qualify as a supercar when other indices of performance are considered? They're pretty heavy for one, and …

  20. comment
    Comment #11539745

    Thanks and thanks. To further bloviate, Tcl is my not-so-secret weapon. I first used it when doing exploratory work with some embedded one-off instruments and it made an impression…

  21. comment
    Comment #11539468

    I don't think there's any simple answer to your specific questions based on what you've provided so far. I'm going to word vomit a bunch of stuff that might, with some Google/Wikip…

  22. story
  23. comment
    Comment #11537397

    Fascinating! and mind-blowing to think about operations on that kind of scale. Thanks for taking the time to share that.

  24. comment
    Comment #11536932

    I'm unclear on how Kuvée fits into the three-tier system [0]. Are they trying to supplement/replace the incumbent distributors, or are they in between the vineyards and distributor…

  25. comment
    Comment #11531019

    I should have also said in the original comment that Little, beyond the website, looks genuinely neat and I'm looking forward to exploring it further. I just finished skimming thro…